The value of routine BMD monitoring after starting bisphosphonate treatment.
Bell
Katy J L
KJ
Hayen
Andrew
A
Irwig
Les
L
Macaskill
Petra
P
Craig
Jonathan C
JC
Ensrud
Kristine E
KE
Bauer
Douglas C
DC
D015519:Bone Density / Q000502:physiology*; D004164:Diphosphonates / Q000627:therapeutic use*; D050723:Fractures, Bone / Q000188:drug therapy; D006801:Humans; D008991:Monitoring, Physiologic; D010349:Patient Compliance; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors
D004164:Diphosphonates